La vendita allo scoperto per Hyster Yale dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Hyster Yale. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Hyster Yale (NYSE:HY) Azioni, Report sulle vendite allo scoperto

Hyster Yale

Hyster-Yale Materials

Hyster-Yale Materials Handling Inc designs, engineers, manufactures, sells and services a comprehensive line of lift trucks, attachments, aftermarket parts and technology solutions marketed globally primarily under the Hyster and Yale brand names.

Hyster Yale Inc

Haymaker Acquisition Corp. 4 Class A Ordinary Shares

Haymaker Acquisition Corp 4

Haymaker Acquisition Corp. 4 Units, each consisting one Class A Ordinary Share and one-half of one redeemable Warrant

Haymaker Acquisition Corp. 4 Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share

New America High Income Fund, Inc. (The) Common Stock

New America High Income Fund Inc

iShares BB Rated Corporate Bond ETF

HYBRID ENERGY HLDGS INC by Hybrid Energy Holdings, Inc.

Hybrid Energy Holdings Inc

NEOS Enhanced Income Credit Select ETF

SPDR Series Trust SPDR Blackstone High Income ETF

HyperBlock Inc

Heyu Biological Technology Corp

TCW High Yield Bond ETF

HANG YICK HLDGS CO LTD by HANG YICK HLDGS CO LTD.

Hang Yick Holdings Co Ltd

VanEck ETF Trust VanEck High Yield Muni ETF

iShares High Yield Systematic Bond ETF

Hydromer Inc

HAYDEN HALL INC (DE) by Hayden Hall, Inc.

Hayden Hall Inc

Global X Hydrogen ETF

Hydra

HYDREIGHT TECHNOLGIES INC by Hydreight Technologies Inc

Hydreight Technologies Inc

Xtrackers Low Beta High Yield Bond ETF

HYDROGEN ENGINE CTR INC by Hydrogen Engine Center, Inc.

Hydrogen Engine Center Inc

VanEck Emerging Markets High Yield Bond ETF

HYUNDAI ELEVATOR CO LTD by Hyundai Elevator Co Ltd.

Hyundai Elevator Co Ltd

HEALTHY EXTRACTS INC by HEALTHY EXTRACTS INC.

Healthy Extracts Inc

AB Active ETFs, Inc. AB High Yield ETF

Hydrofarm Holdings Group, Inc. - Common Stock

Hydrofarm Holdings Group Inc

Hyflux Ltd

iShares iBoxx $ High Yield Corporate Bond ETF

iShares Interest Rate Hedged High Yield Bond ETF

iShares U.S. ETF Trust iShares Inflation Hedged High Yield Bond ETF

HYDROGENETICS INC by Hydrogenetics Inc.

FlexShares High Yield Value-Scored Bond Index Fund

iShares Trust iShares High Yield Corporate Bond BuyWrite Strategy ETF

Sixty Six Capital Inc

ProShares High Yield Interest Rate Hedged

HYGEIA HEALTHCARE HOLDING by HYGEIA HEALTHCARE HOLDINGS CO LTD.

Hygeia Healthcare Holdings Co Ltd

HYDROGEN HYBRID TECHS INC by Hydrogen Hybrid Technologies, Inc.

Hydrogen Hybrid Technologies Inc

Western Asset High Yield Defined Opportunity Fund Inc. Common Stock

Western Asset High Yield Defined Opps.

WisdomTree Alternative Income Fund

ETF Series Solutions Vest 2 Year Interest Rate Hedge ETF

HYAKUGO BANK LTD ORD by Hyakugo Bank Ltd.

Hyakugo Bank Ltd

Xtrackers USD High Yield Corporate Bond ETF

Global X Funds Global X Health Care Covered Call & Growth ETF

Hyliion Holdings Corp. Class A Common Stock

Hyliion Holdings Corp

First Trust Tactical High Yield ETF

SPDR Nuveen Bloomberg High Yield Municipal Bond ETF

Hycroft Mining Holding Corporation - Class A Common Stock

Hycroft Mining Holding Corp

Hycroft Mining Holding Corporation - Warrants

Hycroft Mining Holding Corporation - Warrant

HYUNDAI MOTOR CO by Hyundai Motor Co., Ltd.

Hyundai Motor Co

HYUNDAI MOTOR GDR 144A by Hyundai Motor Co., Ltd.

HYUNDAI MOTOR CO ADR 144 by Hyundai Motor Co., Ltd.

HYUNDAI MOTOR REG S by Hyundai Motor Co., Ltd.

iShares High Yield Muni Income Active ETF

Hyperion

Hypower Fuel Inc

Hypera SA

Hypoport AG

Hypebeast Ltd

Hyperfine Inc

HydrogenPro ASA

HYQC INVESTMENT HLDG CO by HYQC Investment Holding Company

HyreCar Inc

DBX ETF Trust Xtrackers Risk Managed USD High Yield Strategy ETF

PIMCO 0-5 Year High Yield Corporat Bond Index Exchange-Traded Fund

BondBloxx ETF Trust BondBloxx USD High Yield Bond Sector Rotation ETF

Columbia ETF Trust I Columbia Short Duration High Yield ETF

HYSAN DEV CO LTD ORD by Hysan Development Co., Ltd.

Hysan Development Co Ltd

HYSAN DEV CO LTD S/ADR by Hysan Development Co., Ltd.

SunHydrogen Inc

Blackrock Corporate High Yield Fund, Inc. Common Stock

BlackRock Corporate High Yield Fund Inc

HyTerra Ltd

HYTN INNOVATIONS INC by HYTN INNOVATIONS INC.

HYTN Innovations Inc

Counterpoint High Yield Trend ETF

HANKYU HOLDINGS INC by Hankyu Holdings, Inc.

Hankyu Hanshin Holdings Inc

Xtrackers High Beta High Yield Bond ETF

Hyve

HOLLYWOOD INTER INC by Hollywood Intermediate, Inc.

Hollywood Intermediate Inc

HOLLYWOOD STUDIOS INTL by Hollywood Studios International

Hollywood Studios International

iShares ESG Advanced High Yield Corporate Bond ETF

iShares International High Yield Bond ETF

WisdomTree Interest Rate Hedged High Yield Bond Fund

Hyzon Motors Inc

WIIM

Hyster-Yale shares are trading higher after the company announced approval for a $50 million buyback plan to repurchase 1.5 million shares.

"The Board of Directors' approval of this stock repurchase program reflects confidence in the Company's balance sheet and business outlook," said Rajiv K. Prasad, President and Chief Executive Officer of Hyster-Yale, Inc. "This stock repurchase authorization is well aligned with our capital allocation strategy designed to support long-term profitable growth and fuel shareholder return as the business generates free cash flow."

News

Buybacks

Hyster-Yale Approves $50M Buyback Plan, Aims To Repurchase Up To 1.5M Shares

Roth MKM analyst Chip Moore maintains Hyster Yale (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HY#NYSE">HY</a>) with a Buy and lowers the price target from $84 to $70.

Price Target

Analyst Ratings

Roth MKM Maintains Buy on Hyster Yale, Lowers Price Target to $70

<h3>Gainers</h3>
<ul>
<li>Zoomcar Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZCAR#NASDAQ">ZCAR</a>) stock moved upwards by 129.5% to $9.25 during Tuesday's regular session. The market value of their outstanding shares is at $7.0 million. </li>
<li>Aris Water Solutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARIS#NYSE">ARIS</a>) stock increased by 26.26% to $20.91. The market value of their outstanding shares is at $639.1 million. As per the press release, Q3 earnings came out yesterday. </li>
<li>Agrify (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGFY#NASDAQ">AGFY</a>) shares rose 24.84% to $3.92. The market value of their outstanding shares is at $5.2 million. </li>
<li>Li-Cycle Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LICY#NYSE">LICY</a>) stock moved upwards by 22.71% to $3.35. The company's market cap stands at $77.7 million. </li>
<li>DXP Enterprises (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXPE#NASDAQ">DXPE</a>) shares rose 20.64% to $61.43. The company's market cap stands at $969.9 million. As per the press release, Q3 earnings came out yesterday. </li>
<li>WANG &amp; LEE Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WLGS#NASDAQ">WLGS</a>) shares increased by 17.45% to $3.23. The market value of their outstanding shares is at $48.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>JELD-WEN Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JELD#NYSE">JELD</a>) shares declined by 28.5% to $10.11 during Tuesday's regular session. The market value of their outstanding shares is at $854.5 million. The company's, Q3 earnings came out yesterday. </li>
<li>Vast Renewables (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSTE#NASDAQ">VSTE</a>) stock decreased by 23.27% to $5.18. The company's market cap stands at $155.2 million. </li>
<li>Hudson Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HDSN#NASDAQ">HDSN</a>) shares decreased by 22.4% to $5.89. The market value of their outstanding shares is at $268.0 million. The company's, Q3 earnings came out yesterday. </li>
<li>Commercial Vehicle Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVGI#NASDAQ">CVGI</a>) shares fell 21.76% to $2.41. The company's market cap stands at $83.1 million. As per the press release, Q3 earnings came out yesterday. </li>
<li>Hyster Yale (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HY#NYSE">HY</a>) shares declined by 18.12% to $51.33. The market value of their outstanding shares is at $898.2 million. As per the news, the Q3 earnings report came out today. </li>
<li>1847 Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/EFSH#AMEX">EFSH</a>) stock declined by 15.04% to $0.25. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

AGFY

ARIS

CVGI

DXPE

EFSH

HDSN

JELD

LICY

VSTE

WLGS

ZCAR

12 Industrials Stocks Moving In Tuesday's Intraday Session

Hyster-Yale shares are trading lower after the company reported worse-than-expected Q3 financial results. The company also issued expectations for FY25 revenues to be lower than 2024 and for operating profit and net income to decline significantly.

Guidance

Hyster-Yale Expects 2025 Revenues May Be Lower Than 2024 And Operating Profit And Net Income Will Decline Significantly Compared To 2024

Hyster-Yale Expects Consolidated Q4 Revenues And Net Income To Be Roughly Comparable To Prior Year Levels

Hyster Yale (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HY#NYSE">HY</a>) reported quarterly earnings of $0.97 per share which missed the analyst consensus estimate of $1.97 by 50.76 percent. This is a 52.91 percent decrease over earnings of $2.06 per share from the same period last year. The company reported quarterly sales of $1.02 billion which missed the analyst consensus estimate of $1.06 billion by 3.82 percent. This is a 1.50 percent increase over sales of $1.00 billion the same period last year.

Earnings

Earnings Misses

Hyster Yale Q3 2024 GAAP EPS $0.97 Misses $1.97 Estimate, Sales $1.02B Miss $1.06B Estimate

Hyster Yale (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HY#NYSE">HY</a>) will release its quarterly earnings report on Tuesday, 2024-11-05. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Hyster Yale to report an earnings per share (EPS) of $1.97.
Investors in Hyster Yale are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Past Earnings Performance</h3>
During the last quarter, the company reported an EPS beat by $1.47, leading to a 16.42% drop in the share price on the subsequent day.

<h3>Stock Performance</h3>
Shares of Hyster Yale were trading at $62.02 as of November 01. Over the last 52-week period, shares are up 44.76%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<h3>Insights Shared by Analysts on Hyster Yale</h3>
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Hyster Yale.
With 1 analyst ratings, Hyster Yale has a consensus rating of Buy. The average one-year price target is $84.0, indicating a potential 35.44% upside.
<h3>Comparing Ratings with Peers</h3>
This comparison focuses on the analyst ratings and average 1-year price targets of Proto Labs and Helios Technologies, three major players in the industry, shedding light on their relative performance expectations and market positioning.
<ul>
<li>Proto Labs is maintaining an Outperform status according to analysts, with an average 1-year price target of $40.0, indicating a potential 35.5% downside.</li>
<li>The prevailing sentiment among analysts is an Buy trajectory for Helios Technologies, with an average 1-year price target of $63.0, implying a potential 1.58% upside.</li>
</ul>
<h3>Snapshot: Peer Analysis</h3>
In the peer analysis summary, key metrics for Proto Labs and Helios Technologies are highlighted, providing an understanding of their respective standings within the industry and offering insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Hyster Yale</td>
<td>Buy</td>
<td>7.11%</td>
<td>$259.30M</td>
<td>14.42%</td>
</tr>
<tr>
<td>Proto Labs</td>
<td>Outperform</td>
<td>2.75%</td>
<td>$56.55M</td>
<td>0.66%</td>
</tr>
<tr>
<td>Helios Technologies</td>
<td>Buy</td>
<td>-3.38%</td>
<td>$70.60M</td>
<td>1.58%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Hyster Yale ranks at the top for Revenue Growth with 7.11%, outperforming peers. It also leads in Gross Profit at $259.30M, showcasing strong operational efficiency. However, it falls behind in Return on Equity with 14.42%, placing it in the middle compared to peers.
<h3>Discovering Hyster Yale: A Closer Look</h3>
Hyster-Yale Materials Handling Inc designs, engineers, manufactures, sells and services a comprehensive line of lift trucks, attachments, aftermarket parts and technology solutions marketed globally primarily under the Hyster and Yale brand names.
<h3>Hyster Yale's Financial Performance</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Positive Revenue Trend: Examining Hyster Yale's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 7.11% as of 30 June, 2024, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Industrials sector.
Net Margin: Hyster Yale's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 5.42%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 14.42%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 2.99%, the company showcases effective utilization of assets.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 1.08, caution is advised due to increased financial risk.
<a href="https://www.benzinga.com/quote/HY/earnings">To track all earnings releases for Hyster Yale visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Uncovering Potential: Hyster Yale's Earnings Preview

Roth MKM analyst Chip Moore reiterates Hyster Yale (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HY#NYSE">HY</a>) with a Buy and lowers the price target from $87 to $84.

Reiteration

Roth MKM Reiterates Buy on Hyster Yale, Lowers Price Target to $84

Hyster-Yale shares are trading lower. The company reported Q2 financial results.

Hyster-Yale Expects Improved FY 2024 Results; H2 Revenues To Rise With Slightly Moderated Operating Profit; Anticipates Lower Interest And Tax Expense; H2 Net Income Comparable To Strong 2023 Levels; Modest Q3 Decline Offset By Q4 Improvement; Effective Tax Rate Slightly Higher Due To R&D Expense Capitalization

Hyster Yale (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HY#NYSE">HY</a>) reported quarterly earnings of $3.58 per share which beat the analyst consensus estimate of $2.11 by 69.67 percent. The company reported quarterly sales of $1.17 billion which beat the analyst consensus estimate of $1.08 billion by 8.10 percent. This is a 7.16 percent increase over sales of $1.09 billion the same period last year.

Earnings Beats

Hyster Yale Q2 2024 Adj EPS $3.58 Beats $2.11 Estimate, Sales $1.17B Beat $1.08B Estimate

Hyster Yale (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HY#NYSE">HY</a>) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $88.5, along with a high estimate of $90.00 and a low estimate of $87.00. Marking an increase of 3.51%, the current average surpasses the previous average price target of $85.50. 
<img src="https://www.benzinga.com/files/images/story/2024/1717776087_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Hyster Yale. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Chip Moore</td>
<td>Roth MKM</td>
<td>Maintains</td>
<td>Buy</td>
<td>$87.00</td>
<td>$87.00</td>
</tr>
<tr>
<td>Ted Jackson</td>
<td>Northland Capital Markets</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$90.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Ted Jackson</td>
<td>Northland Capital Markets</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$90.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Chip Moore</td>
<td>Roth MKM</td>
<td>Raises</td>
<td>Buy</td>
<td>$87.00</td>
<td>$85.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Hyster Yale. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Hyster Yale compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Hyster Yale's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Capture valuable insights into Hyster Yale's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/HY/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Hyster Yale analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>All You Need to Know About Hyster Yale</h2>
Hyster Yale Inc designs, engineers, manufactures, sells and services a comprehensive line of lift trucks, attachments, aftermarket parts and technology solutions marketed globally primarily under the Hyster and Yale brand names.
<h3>Financial Insights: Hyster Yale</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Hyster Yale's remarkable performance in 3 months is evident. As of 31 March, 2024, the company achieved an impressive revenue growth rate of 5.72%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Industrials sector.
Net Margin: Hyster Yale's net margin excels beyond industry benchmarks, reaching 4.87%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Hyster Yale's ROE excels beyond industry benchmarks, reaching 12.84%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 2.45%, the company showcases effective utilization of assets.
Debt Management: Hyster Yale's debt-to-equity ratio surpasses industry norms, standing at 1.15. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>The Basics of Analyst Ratings</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Where Hyster Yale Stands With Analysts

Roth MKM analyst Chip Moore reiterates Hyster Yale (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HY#NYSE">HY</a>) with a Buy and maintains $87 price target.

Roth MKM Reiterates Buy on Hyster Yale, Maintains $87 Price Target

Northland Capital Markets analyst Ted Jackson upgrades Hyster Yale (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HY#NYSE">HY</a>) from Market Perform to Outperform and maintains the price target from $90 to $90.

Upgrades

Northland Capital Markets Upgrades Hyster Yale to Outperform, Maintains Price Target to $90

Northland Capital Markets analyst Ted Jackson downgrades Hyster-Yale Materials (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HY#NYSE">HY</a>) from Outperform to Market Perform and raises the price target from $80 to $90.

Downgrades

Northland Capital Markets Downgrades Hyster-Yale Materials to Market Perform, Raises Price Target to $90

Roth MKM analyst Chip Moore reiterates Hyster-Yale Materials (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HY#NYSE">HY</a>) with a Buy and raises the price target from $85 to $87.

Roth MKM Reiterates Buy on Hyster-Yale Materials, Raises Price Target to $87

Shares of Upstart Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPST#NASDAQ">UPST</a>) fell sharply during Wednesday's session after the company reported first-quarter financial results and issued second-quarter revenue <a href="https://www.benzinga.com/news/earnings/24/05/38682848/upstart-q1-earnings-revenue-beat-eps-beat-targeting-positive-ebitda-in-2024-and-more">guidance below estimates</a>.
Upstart reported first-quarter revenue of $128 million, which beat the consensus estimate of $124.867 million, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Upstart expects second-quarter revenue of approximately $125 million versus estimates of $140.83 million. The company anticipates a second-quarter adjusted EBITDA loss of approximately $25 million.
Upstart shares dipped 10.3% to $21.96 on Wednesday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Reborn Coffee, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REBN#NASDAQ">REBN</a>) shares jumped 132.9% to $4.0297 after the company announced a significant expansion into the China market through a strategic Master License Agreement with IAID Co.</li>
<li>iSun, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISUN#NASDAQ">ISUN</a>) gained 49% to $0.1966.</li>
<li>NewGenIvf Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIVF#NASDAQ">NIVF</a>) jumped 36.4% to $1.48.</li>
<li>Tivic Health Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIVC#NASDAQ">TIVC</a>) rose 34% to $1.4099.</li>
<li>Innodata Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INOD#NASDAQ">INOD</a>) shares gained 31.5% to $8.86 after the company reported a year-over-year increase in first-quarter financial results.</li>
<li>Cricut, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRCT#NASDAQ">CRCT</a>) gained 31% to $7.25 after the company reported better-than-expected first-quarter GAAP EPS results.</li>
<li>MaxCyte, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MXCT#NASDAQ">MXCT</a>) rose 27.6% to $5.01 following upbeat quarterly results.</li>
<li>Ameresco, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMRC#NASDAQ">AMRC</a>) gained 27.6% to $28.47 following strong quarterly results.</li>
<li>Davis Commodities Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DTCK#NASDAQ">DTCK</a>) rose 26.8% to $1.5580</li>
<li>Elanco Animal Health Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELAN#NYSE">ELAN</a>) surged 26.5% to $17.11 following strong quarterly earnings.</li>
<li>American Public Education, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APEI#NASDAQ">APEI</a>) rose 23.3% to $18.71 following upbeat quarterly results.</li>
<li>Globus Medical, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GMED#NYSE">GMED</a>) gained 23.3% to $63.35 after the company reported better-than-expected first-quarter financial results and raised its FY24 guidance.</li>
<li>Kyndryl Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KD#NYSE">KD</a>) jumped 21.6% to $25.25 after the company reported better-than-expected fourth-quarter financial results.</li>
<li>PowerSchool Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PWSC#NYSE">PWSC</a>) gained 21.2% to $20.17 following a report suggesting Bain is pursuing a takeover of the company.</li>
<li>Myriad Genetics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYGN#NASDAQ">MYGN</a>) rose 21.1% to $24.02 following better-than-expected first-quarter earnings.</li>
<li>Arko Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKO#NYSE">ARKO</a>) gained 20.3% to $5.15 following first-quarter earnings.</li>
<li>Latham Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWIM#NASDAQ">SWIM</a>) gained 19% to $3.5609 following strong first-quarter earnings.</li>
<li>Hyster-Yale Materials Handling, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HY#NYSE">HY</a>) surged 18.2% to $69.74 following UPBEAT first-quarter earnings.</li>
<li>Alpha and Omega Semiconductor Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AOSL#NASDAQ">AOSL</a>) jumped 17.7% to $26.22 after reporting strong quarterly results.</li>
<li>Neo-Concept International Group Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCI#NASDAQ">NCI</a>) gained 17.2% to $1.1529 after declining over 6% on Tuesday.</li>
<li>Oddity Tech Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODD#NASDAQ">ODD</a>) gained 15.8% to $36.19 after the company reported better-than-expected first-quarter financial results and issued FY24 EPS guidance above estimates.</li>
<li>Dutch Bros Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BROS#NYSE">BROS</a>) climbed 15.5% to $32.82 after the company reported better-than-expected first-quarter financial results and raised its FY24 revenue guidance.</li>
<li>Louisiana-Pacific Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LPX#NYSE">LPX</a>) gained 15% to $83.93 following better-than-expected first-quarter financial results.</li>
<li>RingCentral, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNG#NYSE">RNG</a>) rose 14.8% to $34.42 after the company reported better-than-expected first-quarter financial results and raised its FY24 guidance.</li>
<li>Luminar Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAZR#NASDAQ">LAZR</a>) rose 14.5% to $1.89 as the company posted a narrower-than-expected quarterly loss.</li>
<li>Toast, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOST#NYSE">TOST</a>) gained 14.2% to $27.09 after the company reported better-than-expected quarterly sales results.</li>
<li>Hannon Armstrong Sustainable Infrastructure Capital, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HASI#NASDAQ">HASI</a>) gained 13.9% to $29.84 following upbeat earnings.</li>
<li>Teva Pharmaceutical Industries Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEVA#NYSE">TEVA</a>) rose 13% to $15.75 after the company reported mixed first quarter financial results.</li>
<li>Repare Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPTX#NASDAQ">RPTX</a>) gained 11.7% to $3.6650 after the company posted better-than-expected results for its first quarter.</li>
<li>Vistra Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VST#NYSE">VST</a>) gained 10.1% to $90.01 after the company reported first quarter financial results.</li>
<li>Cirrus Logic, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRUS#NASDAQ">CRUS</a>) jumped 9.6% to $99.93 as the company posted better-than-expected results for its fourth quarter.</li>
<li>Clover Health Investments, Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLOV#NASDAQ">CLOV</a>) shares gained 9.5% to $0.81 after the company reported better than expected first-quarter financial results.</li>
<li>Lyft, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYFT#NASDAQ">LYFT</a>) gained 8.8% to $18.08 following better-than-expected first-quarter results.</li>
<li>Veeco Instruments Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VECO#NASDAQ">VECO</a>) rose 6.9% to $40.08 following upbeat results.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Treace Medical Concepts, Inc.. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMCI#NASDAQ">TMCI</a>) shares dipped 60.8% to $4.3650 after the company reported first-quarter financial results and issued FY24 revenue guidance below estimates.</li>
<li>DoubleVerify Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DV#NYSE">DV</a>) fell 38.5% to $18.79 after the company reported first-quarter financial results.</li>
<li>Inspire Medical Systems, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INSP#NYSE">INSP</a>) fell 34.3% to $161.35 following first-quarter results.</li>
<li>Definitive Healthcare Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DH#NASDAQ">DH</a>) dipped 32.2% to $4.9150 after the company reported worse-than-expected first-quarter sales results.</li>
<li>Seres Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCRB#NASDAQ">MCRB</a>) fell 31.1% to $0.7653 following quarterly results.</li>
<li>Tripadvisor, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRIP#NASDAQ">TRIP</a>) fell 28.4% to $18.24 after Liberty Tripadvisor and the Special Committee ceased discussions with third parties with respect to a potential transaction.</li>
<li>ZoomInfo Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZI#NASDAQ">ZI</a>) shares fell 25.2% to $11.98 after the company reported first-quarter financial results and issued second-quarter guidance below estimates.</li>
<li>LegalZoom.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LZ#NASDAQ">LZ</a>) dipped 23.3% to $9.35 after the company reported worse-than-expected first-quarter financial results and issued second-quarter revenue guidance below estimates.</li>
<li>Semler Scientific, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMLR#NASDAQ">SMLR</a>) fell 22.7% to $21.78 after the company reported worse-than-expected first-quarter financial results.</li>
<li>Grocery Outlet Holding Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GO#NASDAQ">GO</a>) dipped 22.2% to $20.17 after the company reported worse-than-expected first-quarter adjusted EPS results.</li>
<li>Flywire Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLYW#NASDAQ">FLYW</a>) shares declined 21.7% to $16.08 after the company reported worse-than-expected first-quarter EPS results and issued second-quarter revenue guidance below estimates.</li>
<li>SIGA Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIGA#NASDAQ">SIGA</a>) dipped 20.6% to $8.31 following first-quarter results.</li>
<li>Shopify Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NYSE">SHOP</a>) fell 19.8% to $61.76 following first-quarter earnings..</li>
<li>Rapid7, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPD#NASDAQ">RPD</a>) dipped 18.6% to $37.26 following first-quarter earnings..</li>
<li>Acutus Medical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFIB#NASDAQ">AFIB</a>) fell 17.1% to $0.1020 after jumping 15% on Tuesday. Nasdaq, last week, notified the company that it has not regained compliance with listing rule 5550(a)(2).</li>
<li>Shoals Technologies Group, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHLS#NASDAQ">SHLS</a>) shares fell 14.1% to $7.56 after the company reported worse-than-expected first-quarter sales results.</li>
<li>Masimo Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MASI#NASDAQ">MASI</a>) fell 13.8% to $117.23 following first-quarter earnings. The company&#8217;s second-quarter guidance midpoint was below consensus estimates.</li>
<li>EchoStar Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SATS#NASDAQ">SATS</a>) dipped 13.6% to $14.99 following worse-than-expected first-quarter financial results.</li>
<li>STAAR Surgical Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STAA#NASDAQ">STAA</a>) dipped 11.8% to $41.10 following quarterly results.</li>
<li>Volcon, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VLCN#NASDAQ">VLCN</a>) shares declined 11.8% to $0.26 after the company reported a year-over-year decrease in first-quarter sales results.</li>
<li>Qualys, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QLYS#NASDAQ">QLYS</a>) fell 10.1% to $149.21 after the company reported first-quarter earnings and issued second-quarter revenue guidance below estimates.</li>
<li>Affirm Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>) fell 9.1% to $31.74 following third-quarter earnings.</li>
<li>Uber Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) dipped 8.6% to $64.40. Uber posted weaker-than-expected fiscal first-quarter financial results.</li>
<li>Coupang, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPNG#NYSE">CPNG</a>) fell 7.8% to $21.78 after the company reported mixed first-quarter financial results.</li>
<li>Astera Labs, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAB#NASDAQ">ALAB</a>) shares declined 6.3% to $71.37 following first-quarter results.</li>
<li>Centrus Energy Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEU#NYSE">LEU</a>) shares declined 6.2% to $41.56 following first-quarter results.</li>
<li>A-Mark Precious Metals Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMRK#NASDAQ">AMRK</a>) shares fell 5.5% to $38.14 following fiscal third quarter 2024 results.</li>
<li>Twilio Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TWLO#NYSE">TWLO</a>) shares fell 5.5% to $59.86 following first-quarter results.</li>
<li>OPKO Health, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPK#NASDAQ">OPK</a>) shares fell 5.4% to $1.23 after the company reported worse-than-expected first-quarter financial results.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/05/38702433/airbnb-gears-up-for-q1-print-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call">Airbnb Gears Up For Q1 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a>

Intraday Update

Markets

AFIB

AFRM

ALAB

AMRC

AMRK

AOSL

APEI

ARKO

BROS

CLOV

CPNG

CRCT

CRUS

DTCK

ELAN

FLYW

GMED

Hannon Armstrong Sustainable Infrastructure Capital

Comments

Hyster Yale

Vendite allo scoperto

Hyster Yale (NYSE:HY) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO